BioHealth Capital Region – Regional Life Sciences Roundup – October 16, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
The BioHealth Capital Region is seeing major investments in research and clinical development, but this week’s bigger story is how those investments are moving science closer to patients. At the University of Maryland, a researcher is joining a consortium backed by up to $51.7 million in ARPA-H funding to predict harmful protein changes linked to Alzheimer’s disease and cancer. Meanwhile, Retension Pharmaceuticals has priced a $45 million IPO to advance its investigational hypertension treatment toward Phase 3 development. Together, these investments reflect a growing focus on tackling complex diseases through both early-stage discovery and clinical advancement.
But the push toward better treatments goes beyond funding. IGC Pharma has introduced its PRISM AI platform to turn Alzheimer’s risk predictions into actionable brain health insights, while Visara has expanded its ophthalmology pipeline through a licensing agreement for an investigational therapy targeting a rare degenerative eye disease. At the same time, the FDA has expanded its approval of ANKTIVA for certain patients with bladder cancer. These developments highlight how companies are approaching unmet medical needs through AI, new therapeutic candidates, and expanded treatment options.
And the infrastructure supporting that progress is evolving alongside science. Johns Hopkins Medicine is partnering with OpenEvidence to bring AI-powered tools into medical education and clinical care, while Northwest Biotherapeutics is collaborating with NHS Blood and Transplant to strengthen manufacturing support for its personalized cancer vaccine. Meanwhile, Maryland is investing $16.4 million in rural healthcare workforce training, helping build the talent pipeline needed to support healthcare delivery. From funding new discoveries and advancing treatments to strengthening the partnerships and workforce behind them, this week’s developments show a region building the capacity to turn innovation into impact.
Financial
Tracking the capital moving through the BioHealth Capital Region — funding rounds, M&A activity, and investment trends shaping Maryland, DC, and Virginia’s life sciences companies.
UMD Joins Up to $51.7M ARPA-H Research Consortium
University of Maryland chemist Pratyush Tiwary is joining a research consortium awarded up to $51.7 million by ARPA-H to predict harmful protein changes linked to Alzheimer’s disease and cancer. The four-year initiative will combine artificial intelligence and experimental research to identify early signs of protein dysfunction. Read More >
Retension Pharmaceuticals Prices $45M IPO
Retension Pharmaceuticals has priced its $45 million initial public offering, marking a major financing milestone for the Virginia biotech. The company plans to use the proceeds to complete Phase 2b trials and advance its lead hypertension treatment, RTN-001, toward Phase 3 development. Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
Mike Davis Joins NSF as Program Officer
Mike Davis, Ph.D., has joined the National Science Foundation (NSF) as a Program Officer in its Directorate for STEM Education. Bringing more than 25 years of community college experience, Davis will support STEM education innovation, institutional capacity building, and workforce development nationwide. Read More >
Cindy Groff-Vindman Appointed to Activation Capital Board
Governor Abigail Spanberger has appointed Cindy Groff-Vindman, Ph.D., to Activation Capital’s board, bringing expertise in biomanufacturing, artificial intelligence, and national security. With experience guiding federal research investments and advancing industrial biotechnology, Groff-Vindman will help support Virginia’s growing life sciences ecosystem. Read More >
Aaron Vernon Joins Allotera Therapeutics
Allotera Therapeutics has Aaron Vernon as Acting Chief Technology Officer as the company advances Sofi-cel, its off-the-shelf CAR-T therapy for T-cell cancers. With more than 20 years of experience in biopharmaceutical manufacturing and technical operations, Vernon will support the company’s development and manufacturing efforts as its pivotal clinical program progresses Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Maryland, DC, and Virginia’s life sciences and biotech employers.
Virginia Western and Radford University sign 3 new agreements to create seamless transfer for medical laboratory science degree
Virginia Western Community College and Radford University are strengthening Southwest Virginia’s healthcare workforce through three new transfer agreements. The partnership creates pathways for students to pursue bachelor’s degrees in medical laboratory science, helping address shortages in the region’s diagnostic laboratory workforce. Read More >
Maryland Awards $16.4M to Expand Rural Healthcare Workforce Training
Maryland has awarded $16.4 million to 39 organizations to expand rural healthcare workforce training and address critical staffing shortages. The investments will support pathways into healthcare careers and strengthen the talent pipeline serving communities across the state. Read More >
Maryland Launches Search Tool Connecting Residents to 900+ Job Training Programs
Governor Wes Moore has announced a new statewide search tool connecting Marylanders with more than 900 job training, adult education, and workforce development opportunities. The platform allows residents to explore programs by industry and location, helping them build career skills while navigating new federal work requirements affecting Medicaid and SNAP benefits. Read More >
Who’s hiring?!
Top Employer
Bora Pharmaceuticals is a global contract development and manufacturing organization (CDMO) dedicated to helping pharmaceutical and biotechnology companies bring medicines from development to commercialization. With expertise in drug development, manufacturing, and quality control, Bora supports the production of high-quality medicines for patients worldwide.
Bora’s teams work across pharmaceutical manufacturing, research and development, quality assurance, and laboratory operations. With opportunities ranging from analytical testing to microbiology leadership, the company offers professionals the chance to contribute to the development and production of essential medicines while advancing their careers in the life sciences industry.
They are currently hiring across 10+ roles across Maryland. Apply Now >
Other employers and available roles we’re paying attention to this week:
- Pharmaceutics International (Prince George, VA) is hiring a Quality Systems Technician | Apply Now >
- Miltenyi Biotec (Washington, DC) is hiring a Senior Flow Cytometry Specialist | Apply Now >
- Javara (Silver Spring, MD) is hiring a Clinical Trial Navigator I | Apply Now >
- Becton Dickinson (Washington, DC) is hiring a Clinical Specialist – Oncology & Infusion Care | Apply Now >
- AstraZeneca (Frederick, Maryland) is hiring a Production Technician| Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across the BioHealth Capital Region.
IGC Pharma Introduces PRISM
IGC Pharma has introduced PRISM to turn Alzheimer’s disease risk predictions into actionable brain health insights. By combining predictive analytics with personalized recommendations, the platform aims to support earlier intervention and more proactive approaches to Alzheimer’s care Read More >
Visara Expands Ophthalmology Pipeline
Visara has secured exclusive licensing rights outside Greater China for an investigational nerve growth factor therapy targeting neurotrophic keratitis, a rare degenerative eye disease. The agreement expands Visara’s clinical-stage pipeline with VIS-102 and supports its efforts to develop new treatments for patients with serious ocular conditions. Read More >
FDA Expands Anktiva Approval for Bladder Cancer
The FDA has expanded its approval of ANKTIVA (nogapendekin alfa inbakicept-pmln) in combination with BCG for certain patients with BCG-unresponsive non-muscle invasive bladder cancer. The expanded indication broadens treatment options for patients facing limited alternatives and marks another regulatory milestone in bladder cancer immunotherapy. Read More >
Ecosystem
The partnerships, programs, and policy moves building the BioHealth Capital Region’s life sciences infrastructure — and the organizations driving it forward.
AI-ready data for predictive models of human biology
The NIH is joining an effort to develop AI-ready scientific data that can support more accurate predictive models of human biology. The initiative aims to strengthen the data infrastructure needed for AI-driven biomedical research, helping researchers better understand biological systems and accelerate scientific discovery. Read More >
DC Startup & Tech Week
BioBuzz is expanding DC Startup & Tech Week’s life sciences programming from a single day to a full week, creating more opportunities for biotech founders, investors, and industry leaders to connect. The expanded track highlights the BioHealth Capital Region’s growing life sciences ecosystem while supporting collaboration, entrepreneurship, and commercialization. Read More>
Northwest Biotherapeutics Partners with UK NHS on Cancer Vaccine Manufacturing
Northwest Biotherapeutics has partnered with NHS Blood and Transplant to expand manufacturing support for DCVax-L, its experimental personalized cancer vaccine for glioblastoma and other solid tumors. Beginning in Leeds and Oxford, the collaboration will strengthen immune cell collection and processing capabilities, with plans to explore expansion across England. Read More >
Johns Hopkins Medicine Partners with OpenEvidence to Develop AI-Powered Clinical Tools
Johns Hopkins Medicine is partnering with OpenEvidence to transform medical education and clinical care through artificial intelligence. The collaboration will develop AI-powered tools that combine peer-reviewed medical research with patient histories and clinical best practices, helping physicians make more informed decisions while preparing future doctors for an AI-driven healthcare environment. Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in DMV biotech and life sciences this week.
Tiny Robots to Deliver Medicine Directly to the Heart
Johns Hopkins researchers have developed magnetically guided miniature robots designed to deliver antibiotics directly to infected heart tissue. Tested in simulated heart environments and pig heart tissue, the technology could eventually offer a less invasive alternative to prolonged antibiotic treatment or open-heart surgery. Read More >
From Crab Trap Winner to Neurotechnology Platform
Following its 2026 BioHealth Capital Region Crab Trap Competition win, Actuated Medical founder Maureen Mulvihill discusses the company’s evolution into neurotechnology, including its precision brain-access platform and efforts to translate medical device innovation into clinical applications. Read More >
A new partner in the fight against cancer
Johns Hopkins cancer researcher Ashani Weeraratna explores how artificial intelligence is accelerating cancer drug discovery, improving early detection, and enabling more personalized treatments, including mRNA cancer vaccines. She also highlights the importance of balancing AI-driven innovation with human scientific judgment as researchers develop the next generation of cancer therapies. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across the BioHealth Capital Region’s life sciences ecosystem that you don’t want to miss.
Women Building Bio 2026 — Connect. Dine. Innovate.
Thursday, October 29 • 4:30–8 PM • Alexandria, VA
Hosted by Virginia Bio | Register Now >
Bio Innovation Conference 2026
Friday, October 23 • 7:30 AM–5:30 PM • Rockville, MD
Hosted by Maryland Tech Council | Register Now >
PDA Pharmaceutical Microbiology Conference 2026
Sunday, October 25–Thursday, October 29 • Washington, DC
Hosted by Parenteral Drug Association (PDA) | Register Now >
Did we miss something!? Drop us a line →
Stay connected to BioHealth Capital Region life sciences.
🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →
Get the BioHealth Capital Region Roundup every Friday.
The week’s most important life sciences news from BioHealth Capital Region— delivered to your inbox.
